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Innate immunity is an essential component in the protection of a host against
pathogens. Enteropathogenic and enterohemorrhagic Escherichia coli (EPEC and
EHEC, respectively) are known to modulate the innate immune responses of infected
cells. The interference is dependent on their type III secretion system (T3SS) and
T3SS-dependent effector proteins. Furthermore, these cytosolically injected effectors
have been demonstrated to engage multiple immune signaling pathways, including the
IFN/STAT, MAPK, NF-κB, and inflammasome pathways. In this review, recent work
describing the interaction between EPEC/EHEC and the inflammasome pathway will be
discussed.
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INTRODUCTION
Enteropathogenic and enterohemorrhagic Escherichia coli (EPEC and EHEC, respectively) are
extracellular pathogens that are transmitted through the ingestion of contaminated food and water.
EHEC produces Shiga toxin (Stx), which can cause diseases of hemorrhagic colitis and, in the worst
case, hemolytic uremic syndromes. In contrast, EPEC does not produce Stx but can still cause
severe gastrointestinal dysfunction, particularly in infants, elders and individuals who are immune
incompetent (Nataro and Kaper, 1998; Croxen et al., 2013). EPEC/EHEC targets and intimately
attaches to the brush boarder of intestinal epithelial cells to produce characteristic attaching and
effacing (A/E) lesions. These lesions are a result of an intense alteration of the host cytoskeleton
into a pedestal-like platform. The pathogenicity of EPEC/EHEC depends on the locus of enterocyte
effacement (LEE), which encodes type III secretion system (T3SS), a syringe-like apparatus, and
secreted virulence factors that are also known as effectors (Moon et al., 1983; McDaniel et al., 1995).
Currently, more than 30 different types of effectors have been experimentally verified (Deng et al.,
2004; Tobe et al., 2006; Blasche et al., 2014).
Host cells are equipped with pattern recognition receptors (PRRs) that recognize conserved
molecules in bacteria. Toll-like receptors (TLRs) are among the well-known PRRs and are located
on the surface and endosomal membrane to detect pathogen-associatedmolecule patterns (PAMPs;
Akira and Takeda, 2004; Kawai and Akira, 2011). Moreover, cytosolic nucleotide-binding domain
(NBD) and leucine-rich repeat-containing (LRR) proteins (NLR, also known as Nod-like receptor)
recognize damage-associated molecule patterns (DAMPs) that arise from cytosolic disturbances or
alien substrates, such as membrane dysfunction, pore-forming toxins, bacterial molecules delivered
into the cytosol via T3SS or type 4 secretion system (T4SS), and bacterial outer membrane vesicles
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(Vanaja et al., 2016). The binding of PAMPs or DAMPs activates
inflammatory signaling pathways and leads to the production
of inflammatory cytokines to further propagate and amplify the
immune response (Mogensen, 2009).
To avoid elimination by the host, A/E pathogens have
acquired arrays of T3SS-dependent effectors to subvert
host-sensing and the activation of inflammatory responses.
Specifically, EPEC/EHEC-mediated suppression of the NF-κB
pathway and the mechanisms of those prominent NF-κB-
suppressive effectors, such as NleB, NleC, NleE, NleH1, and Tir,
have recently become clear and have been reviewed elsewhere
(Santos and Finlay, 2015). In addition to the NF-κB pathway,
an important role of cytosolic NLRs in the sensation of cellular
distress caused by pathogens has been increasingly recognized
(Moltke et al., 2013; Storek and Monack, 2015). Thus, in this
review literature concerning the interactions of NLRs and the
inflammasome pathway with EPEC/EHEC will be discussed.
INFLAMMASOME: SENTINEL OF
CELLULAR DISTURBANCES
The inflammasome refers to a multimeric protein complex
consisting of a sensor, an adaptor, and Caspase-1. The sensor
molecule collectively known as NLR is characterized by the
presence of a nucleotide-binding domain (NBD) and a leucine-
rich repeat (LRR) and can be further categorized into subfamilies
with the following distinctive N-terminal effector domains: acidic
transactivation domain, pyrin domain, caspase recruitment
domain (CARD), and baculoviral inhibitory repeat (BIR)-like
domain (Ting et al., 2008; Latz et al., 2013). Upon sensing
stimuli, the sensor NLR protein recruits the adaptor protein
ASC. ASC is a common component of all of the inflammasome
and contains both pyrin and CARD domains that can bridge
the NLR molecule and inactive pro-Caspase-1. Subsequently,
the incorporation of pro-Caspase-1 into the NLR-ASC complex
allows these zymogens to come in close proximity to each
other to promote oligomerization and auto-proteolytic cleavage
into active Caspase-1 (Yang et al., 1998). Consequently, active
Caspase-1 goes on to digest diverse substrates, including pro-IL-
1β and pro-IL-18 (Thornberry et al., 1992; Shao et al., 2007; Latz
et al., 2013).
One of the most studied NLR proteins is NLRP3. The full
activation of the NLRP3-inflammasome pathway requires two
steps, i.e., a priming step to activate NF-κB and an activation
step to trigger the assembly of the NLRP3/ASC/Caspase-
1 complex (Figure 1). Priming is important for the full
activation of the NLRP3-inflammasome and begins with the
recognition of an NF-κB-activating stimuli, such as PAMP-TLR
bindings (the prime example being the binding between LPS
and TLR4). This recognition activates the NF-κB-dependent
transcription of NLRP3 and IL-1β and the NF-κB-independent
de-ubiquitin modification of the NLRP3 protein (Bauernfeind
et al., 2009; Juliana et al., 2012; Py et al., 2013). Subsequent
to the priming step, the NLRP3-inflammasome assembly is
triggered by NLRP3-activating stimuli, which range from
metabolic dysregulation (i.e., exposure to uric acid crystals,
cholesterol crystals, alum, or extracellular ATP) to infection (i.e.,
bacterial RNAs, pore-forming toxins, and cytosolically delivered
proteins via T3SS/T4SS). This apparent broad responsiveness
of NLRP3 suggests that rather than direct recognition of
activating agonists, activators may indirectly induce a common
downstream perturbation in cellular physiology that leads to
the activation of NLRP3. To date, experimentally demonstrated
cellular disturbances include potassium eﬄux (Muñoz-Planillo
et al., 2013; Katsnelson et al., 2015), increase in intracellular
calcium (Lee et al., 2012; Murakami et al., 2012), the generation
of mitochondrial reactive oxygen species (ROS; Zhou et al.,
2011), and mitoDNA or cardiolipin (Nakahira et al., 2011;
Shimada et al., 2012; Iyer et al., 2013), the release of cathepsin
from the disturbed lysosome (Hornung et al., 2008), and the
translocation of NLRP3 to the mitochondria (Misawa et al., 2013;
Subramanian et al., 2013). However, one needs to be cautious
because not every known NLRP3 agonist can induce all of
these cellular changes, and the true mechanism(s) of NLRP3
activation remains to be verified. Recently, a non-canonical
NLRP3 inflammasome has also been described during infection
by enteric pathogens (Kayagaki et al., 2011). This non-canonical
NLRP3 pathway involves not only TRL4- and MyD88-mediated
NLRP3 upregulation but also the TLR4-TRIP mediated type-I
interferon-dependent production of Caspase-11 (Caspase-4 in
humans) for maximal Caspase-1 capacity (Wang et al., 1998;
Kayagaki et al., 2011; Gurung et al., 2012; Rathinam et al.,
2012). This requirement of Caspase-4/-11 for optimal Caspase-
1 activation appears to be non-essential for agonists of metabolic
dysregulation (Kayagaki et al., 2011).
NLRC4 is another well-studied NLR protein. NLRC4 differs
from NLRP3 not only in structure because it has a CARD
domain at its N-terminus but also in response; NLRC4 responds
to a different and a narrower set of immunogenic agonists.
These agonists are mainly the components of T3SS and T4SS
(Miao and Warren, 2010; Zhao and Shao, 2015). The CARD
motif in NLRC4 allows it to recruit pro-Caspase-1 directly
without ASC; however, the incorporation of ASC can maximize
the activity of the NLRC4-inflammasome (Mariathasan et al.,
2004). Currently there is no evidence demonstrating a direct
association of the NLRC4 sensor with its agonists. Rather, studies
have confirmed that NLRC4 utilizes co-factors, specifically NLR
apoptosis inhibitory protein (NAIP), to distinguish ligands
(Tenthorey et al., 2014). Upon recognition of a specific ligand,
NAIP then binds to NLRC4 to induce the formation of the
NLRC4 inflammasome. In humans, there is one NAIP protein,
whereas there are four Naip paralogs that have been confirmed
in C57BL/6J mice, including Naip1, Naip2, Naip5, and Naip6.
Naip1 shares the greatest homology with the human NAIP and
recognizes T3SS needle proteins (Rayamajhi et al., 2013; Yang
et al., 2013). Naip2 binds to T3SS rod proteins, and both Naip5
and Naip6 interact with bacterial flagellin (Kofoed and Vance,
2011; Zhao et al., 2011). Notably, not all flagellins or T3SS
components can be recognized by the described Naip/NAIP
members. For example, while Naip5 and 6 recognize flagellin
from Salmonella spp., they do not associate with the flagellins of
EPEC and EHEC and hence fail to elicit NLRC4 activation (Zhao
et al., 2011).
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FIGURE 1 | Interplay between EPEC/EHEC and inflammasome. Host cells detect and respond to the cellular disturbance from the T3SS-dependent infection of
EPEC and EHEC. The sensing of bacterial presence begins when PRRs on the cell membrane recognize PAMPs (for example. LPS by TLR4). This engagement
initiates the activation of NF-κB signaling and allows the production of inflammasomal components, including NLRP3 and Pro-IL-1β. Moreover, the detection of
PAMPs also triggers the deubiquitination of NLRP3, readying for the sensor protein to assemble the signature complex of NLRP3/ASC/Caspase-1. In the case of
NLRP3, the complex formation also requires a secondary stimuli from the infection (for example, the disruption of membrane integrity by Ehx-toxin or the presence of
bacterial-derived DNA:RNA hybrids). NLRC4 initiates the complex assembly after Naip proteins binds to respective ligands. Ultimately, pro-IL-1β is processed to a
secretion-competent form. EPEC and EHEC use multiple effectors to interfer NF-κB and inflammasome pathways. Currently, only a limited numbers of effectors
known to directly target components of the inflammasome complex; they are NleA, NleB, and NleF. NleA directly interacts with NLRP3 to interrupt ubiquitin
modification of NLRP3; NleB may negatively influence FADD/Caspase-8, which enhances NLRP3-inflammasome activity; NleF may potentially disrupt
NLRP3-inflammasome by inhibiting Caspase-4 and Caspase-8.
Mice lacking components of the NLRP3- or NLRC4-
inflammasome have been found to be more susceptible to
infection by various bacterial pathogens (Mariathasan et al., 2005;
Lara-Tejero et al., 2006; Raupach et al., 2006; Suzuki et al., 2007).
The in vivo contribution of host NLRP3 andNLRC4 to act against
A/E pathogens have been evaluated using Citrobacter rodentium
(C. rodentium), which is amouse-adapted A/E pathogen (Alipour
et al., 2013). Mice lacking Nlrp3 and/or Nlrc4 carry higher
pathogen burdens and exhibit more severe colitis. Dissection
of the contributions of the cellular compartments has revealed
that cecum-derived E-cadherin+ intestinal epithelial cells (IEC)
express high amounts of ASC adaptor, and Nlrp3 and Nlrc4
activation are both critical for protection against C. rodentium
early in the course of infection (Nordlander et al., 2014; Song-
Zhao et al., 2014). However, at later times after infection,
the Nlrp3 response mounted by macrophages appears to be
indispensable for reducing the severity of the histopathology (Liu
et al., 2012).
ACTIVATION OF THE INFLAMMASOME
PATHWAY BY EPEC/EHEC
Studies of the mechanisms of inflammasome activation
during bacterial infection have also provided insight into the
components of EPEC/EHEC that are capable of provoking
inflammasome pathways. These components include T3SS/E.
coli type III secretion system 2 (ETT2) components of EPEC
and/or EHEC (Miao et al., 2010a; Zhao et al., 2011; Yang
et al., 2013), enterohemolysin (Ehx) of EHEC (Zhang X. et al.,
2012), and DNA:RNA hybrid molecules (Kailasan Vanaja et al.,
2014).
Among the T3SS components, both the inner rod proteins
of T3SS and ETT2 (EscI and EprJ, respectively) can activate
Caspase-1 via the Naip-Nlrc4 inflammasome. Moreover, the
needle protein of ETT2 (EprI) but not that of T3SS (EscF) is
able to stimulate IL-1β maturation (Miao et al., 2010b; Zhao
et al., 2011; Yang et al., 2013). Interestingly, genomic analysis
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 3 August 2016 | Volume 6 | Article 89
Yen et al. EPEC/EHEC Manipulates Inflammasome
and functional studies have provided little evidence of functional
ETT2 in EHEC or EPEC due to a partial truncation of the
encoding loci (Makino et al., 2003; Ren et al., 2004). Although
some E. coli strains possess an intact ETT2 gene set and may
express it, the true physiological relevance of ETT2 components
in eliciting Naip/NLCR4-inflammasome activation due to EHEC
remains controversial.
In addition to the T3SS and ETT2 components that activate
the Naip-Nlrc4 inflammasome, EHEC-specific enterohemolysin
(Ehx) has been found to stimulate the maturation of Caspase-
1 and IL-1β (Zhang X. et al., 2012). Ehx is a pore-forming
toxin encoded on a plasmid that is conserved in most
EHEC strains and can cause apoptosis in macrophages and
colonic epithelial cells (Schmidt et al., 1995; Menestrina et al.,
1996; Fernandez-Prada et al., 1998; Figueiredo et al., 2007).
Using siRNA silencing of genes encoding components of the
inflammasome complex, Zhang et al. demonstrated that this
toxin stimulates the production of mature IL-1β, and this
process is partially dependent on NLRP3/ASC/Caspase-1 in
human macrophage-like cells (Zhang X. et al., 2012). Given
the pore-forming ability of Ehx, this toxin-induced IL-1β
production is similar to that of other pore-forming toxins found
in different bacterial species that are all known to activate
the NRLP3-inflammasome (Gurcel et al., 2006; Mariathasan
et al., 2006; Craven et al., 2009). Because these toxins differ
in structure, the disruption of the cellular membrane may
be the common cause of the stimulation of NLRP3 activity.
At the present time, there are no reports on the Ehx-like
molecules that cause inflammasome activity in EPEC and C.
rodentium.
In addition to Ehx, RNA:DNA hybrid molecules of EHEC
have also been demonstrated to stimulate NLRP3 inflammasome-
dependent IL-1β production (Kailasan Vanaja et al., 2014).
The authors of this study demonstrated that, following
the phagocytosis of EHEC by mouse bone-marrow-derived
macrophages, bacterial RNA:DNA molecules translocate from
the Lamp-1-positive lysosome into the cytosolic compartment
and colocalize with NLRP3. This colocalization is accompanied
with the activation of Caspase-1 and the maturation of IL-1β
(Kailasan Vanaja et al., 2014). The sensors of dsDNA (AIM2)
and dsRNA (PKR) were found to be dispensable. Currently, the
receptor andmechanisms responsible for bringing theDNA:RNA
hybrid to NLRP3 remain unknown. This stimulatory property of
RNA:DNA hybrids has been confirmed via the use of synthetic
RNA:DNA molecules and an RNase H-deficient E. coli that
accumulates RNA:DNA (Kailasan Vanaja et al., 2014; Vanaja
et al., 2015). Therefore, this NLRP3-linked defense mechanism
may not be EHEC-specific but rather a general host mechanism
for the detection of bacteria in the cytosol.
INTERFERENCE WITH THE
INFLAMMASOME PATHWAY BY
EPEC/EHEC
The power balance between host immune responses and
pathogens dictate the outcome of the infection. In the case of
EPEC/EHEC, T3SS-dependent effectors have been demonstrated
to modulate various immune signaling pathways (Santos and
Finlay, 2015). In addition to the central role of NF-κB in many
immune responses, NF-κB is also critical for the activation
of the NLRP3-inflammasome because reduced NF-κB activity
influences the transcription of NLRP3 and IL-1β (Figure 1;
Bauernfeind et al., 2009; Qiao et al., 2012). However, whether
the transcription of NLRC4 is similarly regulated by NF-κB is
unknown. Thus far, many studies have revealed a great deal
of NF-κB-targeting effectors in EPEC/EHEC. Major NF-κB-
targeting effectors include NleB, NleC, NleE, NleH1, and Tir
(Gao et al., 2009; Nadler et al., 2010; Newton et al., 2010;
Royan et al., 2010; Vossenkämper et al., 2010; Yen et al., 2010;
Baruch et al., 2011; Mühlen et al., 2011; Ruchaud-Sparagano
et al., 2011; Wan et al., 2011; Zhang L. et al., 2012; Gao
et al., 2013). Because NF-κB signaling is a prerequisite to
the onset of the NLRP3 inflammasome, all of these effectors
are expected to contribute to the dampening of NLRP3
activity.
In addition to NF-κB-suppressing effectors, functional studies
of other effectors have also yielded evidence that components of
the inflammasome are being directly targeted (Table 1; Figure 1).
NleA is one such effector that has recently been demonstrated
to directly target the NLRP3 protein to prevent Caspase-1
activation (Yen et al., 2015). Initial studies revealed that NleA
is a blocker of ER-Golgi transportation (Gruenheid et al., 2004;
Kim et al., 2007). Recently, Yen et al. used effector-compound
deletion mutants of EPEC to screen for effectors that are able
to reduce IL-1β production and isolated NleA (Yen et al.,
2015). This reduction in IL-1β due to NleA was not a result
of NF-κB inhibition but was rather due to an effect on the
assembly of the NLRP3/ASC/Caspase-1 complex. Analysis of
the host target revealed that NleA can directly associate with
non-ubiquitinated and ubiquitinated NLRP3. Furthermore, this
effector has been demonstrated to be capable of interrupting
the deubiquitination of NLRP3, which is a pre-requisite to
the assembly of the NLRP3/ASC/Caspase-1 complex. How this
association negatively affects the de-ubiquitination of NLRP3
is unclear. Thus far, NleA has not been experimentally proven
to possess E3-ubiquitin ligase-like activity, and whether this
inference with NLRP3 modification is the result of E3 activity
is unknown. Another possibility is that because BRCC3 is the
sole identified host deubiquitinase of NLRP3 (Py et al., 2013),
the association of NleA and NLRP3 may impede the access of
BRCC3 to the sensor protein. Therefore, further investigation is
required to provide fuller insight into the mechanistic action of
NleA.
NleB1 and NleB2 are inhibitors of the Tumor necrosis
factor (TNF)-NF-κB signaling axis and are N-acetylglucosamine
(GlcNac) transferases (Nadler et al., 2010; Newton et al.,
2010; Gao et al., 2013). Moreover, NleB1 can interact
with an array of death domain-containing proteins, such
as TFNR1-associated death domain (TRADD) and FAS-
associated death domain (FADD; Li et al., 2013; Pearson
et al., 2013). Specifically, TRADD and FADD are both critical
to the TNF-receptor-mediated activation of NF-κB and to
the onset of downstream Caspase 8-dependent apoptosis
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 4 August 2016 | Volume 6 | Article 89
Yen et al. EPEC/EHEC Manipulates Inflammasome
TABLE 1 | Molecules of EPEC and EHEC that interact with the inflammasome.
Molecule EPEC or EHEC specific Inflammasome and/or Sensors Known Function/Inflammasome
manipulation
References
EprJ EHEC Nlrc4 (murine) Inner rod protein of ETT2. Induce murine
NLRC4 activation. Type of NAIP protein for
the recognition is unknown.
Miao et al., 2010a
EscI Both Naip2/Nlrc4(murine); NLRC4 (human) Inner rod protein of T3SS. Induce NLRP4
in a murine Naip2-dependent manner.
Recognition by human NAIP is unknown.
Miao et al., 2010b; Zhao et al.,
2011
EprI EHEC Naip1 (murine); NAIP (human) A needle protein of ETT2. Induce
murine/human NAIP1-dependent
activation of NLRC4.
Yang et al., 2013; Zhao and
Shao, 2015
NleA Both * NLRP3 Inhibit NLRP3-inflammasome formation.
Interferes state of NLRP3 ubiquitination.
Yen et al., 2015
NleB Both * NLRP3 (?) Glycosyltransferase; Inhibitor of NF-κB
and FADD/Caspase-8 apoptosis; A
potential inhibitor of non-Canonical NLRP3
inflammasome by suppressing
FADD/Caspase-8.
Gao et al., 2013; Li et al., 2013;
Pearson et al., 2013
NleF Both * NLRP3 (?) Inhibitor of Caspase-4,-8, and -9
associated cell death; A pseudosubstrate
of Caspase-9; A potential
pseudosubstrate to Caspase-4 and -8 by
blocking non-canonical NLRP3
inflammasome activity.
Blasche et al., 2013
*NleA, NleB, and NleF are also present in Citrobacter rodentium and rabbit enteric pathogenic Escherichia coli O15:K-:NM (strain RDEC-1).
(Micheau and Tschopp, 2003). In the most recent studies,
FADD and Caspase-8 have been linked to the regulation of
the non-canonical NLRP3 inflammasome. In this process,
Caspase-8 augments the NLRP3 inflammasome (Gurung
et al., 2014; Antonopoulos et al., 2015; Kang et al., 2015).
Thus, in addition to the known NF-κB inhibition, NleB may
also provide additional negative regulation of the NLRP3
inflammasome.
NleF is an inhibitor of several Caspase family members,
including Caspases-4, 8, and 9 (Blasche et al., 2013). Although
the pro-survival effect of NleF is only apparent on ectopic
expression, an in-depth analysis of the crystallized structure
of the NleF-Caspase-9 protein complex revealed that the
effector inserts its carboxyl terminus amino acids, i.e., Gly189,
Cys188, Gln187, and Leu186, into the active pockets of the
protease. Modification of the carboxyl terminus of NleF by
either adding amino acids or deleting the last four amino
acids abolishes the activity of NleF. Such biomimicry involving
posing as a pseudosubstrate of Caspase enzymes has also
been reported in YopM of Yersinia; here, YopM targets
Caspase-1 (LaRock and Cookson, 2012). Because Caspase-4
and Caspase-8 both positively participate in non-canonical
NLRP3-inflammasome activation, and endogenous bacterially
injected NleF has been reported to be low in abundance
(Echtenkamp et al., 2008), NleF may serve as a fail-safe
mechanism to ensure finer control of the inflammasome
pathway.
In vivo studies have demonstrated that NleA, NleB, and
NleF all are important for colonization and pathology in the
C. rodentium model of infection (Gruenheid et al., 2004; Kelly
et al., 2006; Echtenkamp et al., 2008). Because effectors possess
multiple host targets, it is reasonable to speculate that their
interference with the inflammasome pathways contributes to
the overall bacterial fitness in terms of establishing a successful
infection.
CONCLUDING REMARKS
IL-1β and related cytokines are critical to host defense in terms
of enhancing innate and adaptive immunity against a broad
range of pathogens (Netea et al., 2010). In retrospect, this
evolutionary selective pressure allows or forces pathogens to
develop strategies to counteract the inflammasome pathway,
which is an indispensable component of IL-1β production
(reviewed elsewhere, Cunha and Zamboni, 2013). Currently,
although there is only limited direct evidence of effectors
subverting the inflammasome pathway, a close examination
of many prior functional studies reveals that EPEC/EHEC,
which are similar to other pathogens, have evolved diverse
methods that target multiple steps of inflammasome activation
(Table 1; Figure 1). Although the reason that A/E pathogens
possess molecules that display the opposite effect on the
inflammasome activity is unclear, it is likely that the balanced
activities by both types of molecules is important for infection.
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In closing, as many studies have used immune cells to
examine the molecular interactions between inflammation
and EPEC/EHEC, future studies should utilize intestinal
epithelial cells to allow for a deeper appreciation of the
complex interaction between the host immune system and A/E
pathogens.
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